Empowering the CRISPR/Cas9 platform globally

ERS’s collaborative licensing approach promotes widespread adoption of CRISPR/Cas9 technology.

Non-exclusive licenses are available to companies involved in development and commercialization of CRISPR/Cas9 technology, products, and services.

Licenses are available in a wide range of fields

  • Pharmaceutical & Biotechnology
  • CROs, CMOs & Tool Providers
  • Companion Animal & Veterinary Applications
  • Agriculture & Livestock applications
  • Industrial & Synthetic Biology Applications

Some of our 100+ Licensees

Internal
Research
Industrial Bio
Production
CRO’s
CMO’s
Tools /
Reagents